ViroPharma, Inc. (VPHM)

CAPS Rating:

A biopharmaceutical company dedicated to the development and commercialization of products that address serious infectious diseases, with a focus on products used by physician specialists or in hospital settings.

View All Commentary (VPHM)

Recs

1

Avatar zzlangerhans (98.66) Submitted: 7/22/08 11:49 AM : Start Price: $9.82 VPHM Score: 43.04

I like the Lev deal since I think it Cinryze is going to get approved and Viropharm got a fair if not fire sale price for the company. Marabivir phase III results could also represent a significant near term positive catalyst.

Report this Post Replies: 2 | Reply

Avatar EnigmaDude (32.15) Submitted: 8/20/08 10:58 AM

Recs: 0 | Rec This

I just read their annual report and I agree that these developments have great long-term potential. And the fact that you like them makes it even more appealing!

Report this Post Reply

Avatar zzlangerhans (98.66) Submitted: 10/12/08 12:04 PM

Recs: 0 | Rec This

Oops, just realized I forgot to write my pick closing comment, and OCD won't allow me to let it go. I still felt long-term positive on Viropharm when I closed the pick but I didn't like the quivering and straining I was seeing at 14. I smelled a short-term correction coming, and the rest is history.

Report this Post Reply

ViroPharma, Inc. (VPHM)

1

Featured Broker Partners